Cargando…
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526187/ https://www.ncbi.nlm.nih.gov/pubmed/31190746 http://dx.doi.org/10.2147/DDDT.S207537 |
| _version_ | 1783419849431580672 |
|---|---|
| author | Abe, Mitsuhiro Tsushima, Kenji Tatsumi, Koichiro |
| author_facet | Abe, Mitsuhiro Tsushima, Kenji Tatsumi, Koichiro |
| author_sort | Abe, Mitsuhiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6526187 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65261872019-06-12 Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] Abe, Mitsuhiro Tsushima, Kenji Tatsumi, Koichiro Drug Des Devel Ther Response to Letter Dove 2019-05-14 /pmc/articles/PMC6526187/ /pubmed/31190746 http://dx.doi.org/10.2147/DDDT.S207537 Text en © 2019 Abe et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Abe, Mitsuhiro Tsushima, Kenji Tatsumi, Koichiro Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title | Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title_full | Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title_fullStr | Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title_full_unstemmed | Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title_short | Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Response to letter] |
| title_sort | utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526187/ https://www.ncbi.nlm.nih.gov/pubmed/31190746 http://dx.doi.org/10.2147/DDDT.S207537 |
| work_keys_str_mv | AT abemitsuhiro utilityofnintedanibforsevereidiopathicpulmonaryfibrosisasinglecenterretrospectivestudyresponsetoletter AT tsushimakenji utilityofnintedanibforsevereidiopathicpulmonaryfibrosisasinglecenterretrospectivestudyresponsetoletter AT tatsumikoichiro utilityofnintedanibforsevereidiopathicpulmonaryfibrosisasinglecenterretrospectivestudyresponsetoletter |